View Single Post
Old 11-12-2016, 11:05 PM
zanpar321 zanpar321 is offline
Member
 
Join Date: Feb 2014
Posts: 365
10 yr Member
zanpar321 zanpar321 is offline
Member
 
Join Date: Feb 2014
Posts: 365
10 yr Member
Default Prothena reports 97 % reduction of alpha synuclein after 1 dose!

Progress in reducing alpha synuclein but another year has gone by!

Prothena Reports Results from Phase 1b Study of PRX2 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson's Disease (NASDAQ:PRTA)
zanpar321 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (11-13-2016), GerryW (11-13-2016), jeffreyn (11-13-2016), johnt (11-13-2016), lab rat (11-15-2016), Niggs (11-13-2016), sim00 (12-02-2016)